US Senate hearings put focus on alternatives to overuse of antipsychotics in nursing homes

2 December 2011

US Senator Herb Kohl (Democrat, Wisconsin), Chairman of the Special Committee on Aging, held a hearing this week examining the widespread inappropriate use of antipsychotics among nursing home residents suffering from dementia, high costs to taxpayers and the efforts to find safe and effective alternatives.

“When properly prescribed, antipsychotics can offer beneficial treatment for individuals suffering from mental illness,” Sen Kohl said, “however, we have a responsibility to patients and their families to ensure that elderly nursing home residents are free from all types of unnecessary drugs, and we have a responsibility to taxpayers to be certain that they are not paying for drugs that are not needed.”

The hearing highlighted two recent investigations by the Department of Health and Human Services Office of Inspector General (HHS OIG) that looked at the prevalent use of atypical antipsychotics in the face of a Food and Drug Administration “black box” warning and the high costs to taxpayers.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight